(Q41571665)

3 October 2017

1 reference

title

Cell-cycle control and renal disease (English)

1 reference

3 October 2017

Shankland SJ

1

1 reference

3 October 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

3 October 2017

1 reference

3 October 2017

volume

52

1 reference

3 October 2017

issue

2

1 reference

3 October 2017

page(s)

294-308

1 reference

Growth factors in glomerulonephritis

3 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Mechanisms of progressive renal disease in glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Cellular events in the evolution of experimental diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Sequential protein kinase reactions controlling cell growth and differentiation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

G1 events and regulation of cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Animal cell cycles and their control

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

What is the restriction point?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Principles of CDK regulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Inhibitors of mammalian G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Apoptosis and the cell cycle.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Replicative senescence: implications for in vivo aging and tumor suppression

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Control of cell cycle entry and progression in mitogen-stimulated human B lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Cyclin dependent kinase regulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Functional analysis of the human cyclin D2 and cyclin D3 promoters

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Structure and cell cycle-regulated transcription of the human cyclin A gene

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Cyclins and cyclin-dependent kinases: a biochemical view

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Identification of the domains in cyclin A required for binding to, and activation of, p34cdc2 and p32cdk2 protein kinase subunits

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.1997.335

1 reference

7 January 2021

Isolation of three novel human cyclins by rescue of G1 cyclin (cln) function in yeast

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Functional interactions of the retinoblastoma protein with mammalian D-type cyclins

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Cyclin D1 is a nuclear protein required for cell cycle progression in G1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Human cyclin E, a nuclear protein essential for the G1-to-S phase transition

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Cyclin-dependent regulation of G1 in mammalian fibroblasts.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Cyclin A is required at two points in the human cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Cyclin a is required for the onset of DNA replication in mammalian fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

A link between cyclin A expression and adhesion-dependent cell cycle progression

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

The ATF site mediates downregulation of the cyclin A gene during contact inhibition in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Inhibition of G1 phase cyclin dependent kinases by transforming growth factor beta 1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Cdc2 regulatory factors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Destruction of Xenopus cyclins A and B2, but not B1, requires binding to p34cdc2.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Cyclin is degraded by the ubiquitin pathway

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Crystal structure of cyclin-dependent kinase 2

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Sequences within the conserved cyclin box of human cyclin A are sufficient for binding to and activation of cdc2 kinase

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Cdc2 activation: the interplay of cyclin binding and Thr161 phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Identification of G1 kinase activity for cdk6, a novel cyclin D partner

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Universal control mechanism regulating onset of M-phase

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Characterization of the human cyclin-dependent kinase 2 gene. Promoter analysis and gene structure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Primary response genes induced by growth factors and tumor promoters

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Targets of cyclin-dependent protein kinases.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

The retinoblastoma protein and cell cycle control

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

DP and E2F proteins: components of a heterodimeric transcription factor implicated in cell cycle control

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

E2F: a link between the Rb tumor suppressor protein and viral oncoproteins

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Cdk inhibitors: on the threshold of checkpoints and development

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Effects of TGF-beta 1 (transforming growth factor-beta 1) on the cell cycle regulation of human breast adenocarcinoma (MCF-7) cells.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Inhibition of cyclin-dependent kinases by p21

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

p21 is a universal inhibitor of cyclin kinases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Proliferating cell nuclear antigen is required for DNA excision repair

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

A 39 amino acid fragment of the cell cycle regulator p21 is sufficient to bind PCNA and partially inhibit DNA replication in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Radiation-induced cell cycle arrest compromised by p21 deficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Translational control of p27Kip1 accumulation during the cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

New tumor suppressor may rival p53

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

The progression of renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Dietary protein restriction rapidly reduces transforming growth factor beta 1 expression in experimental glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Increased synthesis of extracellular matrix in mesangial proliferative nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Renal hypertrophy in experimental diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

The biology of renal hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kip1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Involvement of pRB family in TGF beta-dependent epithelial cell hypertrophy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Disappearance of cyclin A correlates with permanent withdrawal of cardiomyocytes from the cell cycle in human and rat hearts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Loss of mitotic activity and the expression of vimentin in glomerular epithelial cells of developing human kidneys

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Differential expression of transforming growth factor-beta isoforms and receptors in experimental membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Control of rat glomerular epithelial cell growth in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Transforming growth factor beta in tissue fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Rat mesangial cell hypertrophy in response to transforming growth factor-beta 1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Angiotensin II-stimulated hypertrophy of LLC-PK1 cells depends on the induction of the cyclin-dependent kinase inhibitor p27Kip1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.335

7 January 2021

Identifiers

DOI

10.1038/KI.1997.335

1 reference

3 October 2017

1 reference